Zyrtec Related Published Studies
Well-designed clinical trials related to Zyrtec (Cetirizine)
Comparison of the sedating effects of levocetirizine and cetirizine: a randomized, double-blind, placebo-controlled trial. [2011.12]
Efficacy and safety of bilastine 20 mg compared with cetirizine 10 mg and placebo in the treatment of perennial allergic rhinitiss. [2011.11.30]
A comparative analysis of cetirizine, gabapentin and their combination in the relief of post-burn pruritus. [2011.03]
Pharmacokinetics and effects of cetirizine in horses with insect bite hypersensitivity. [2011.03]
Anti-inflammatory activity and clinical efficacy of a 3-month levocetirizine therapy in mite-allergic children. [2011.02]
Determination of cetirizine in human plasma using high performance liquid chromatography coupled with tandem mass spectrometric detection: application to a bioequivalence study. [2011]
Morning and evening efficacy evaluation of rupatadine (10 and 20 mg), compared with cetirizine 10 mg in perennial allergic rhinitis: a randomized, double-blind, placebo-controlled trial. [2011]
Nasal nitric oxide and nasal eosinophils decrease with levocetirizine in subjects
with perennial allergic rhinitis. [2011]
Use of montelukast alone or in combination with desloratadine or levocetirizine
in patients with persistent allergic rhinitis. [2011]
Anti-inflammatory activity and clinical efficacy of a 3-month levocetirizine
therapy in mite-allergic children. [2011]
Rupatadine and levocetirizine for seasonal allergic rhinitis: a comparative study of efficacy and safety. [2010.08]
Safety and tolerability of levocetirizine dihydrochloride in infants and children with allergic rhinitis or chronic urticaria. [2010.07]
Study of levocetirizine in seasonal allergic rhinitis. [2010.06]
The effects of bilastine compared with cetirizine, fexofenadine, and placebo on allergen-induced nasal and ocular symptoms in patients exposed to aeroallergen in the Vienna Challenge Chamber. [2010.05]
Comparison of the efficacy and safety of bilastine 20 mg vs levocetirizine 5 mg for the treatment of chronic idiopathic urticaria: a multi-centre, double-blind, randomized, placebo-controlled study. [2010.04]
Efficacy and safety of levocetirizine in improving symptoms and health-related quality of life in US adults with seasonal allergic rhinitis: a randomized, placebo-controlled study. [2010.03]
The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria. [2010.03]
Clinical assessment of levocetirizine and budesonide in treatment of persistent allergic rhinitis regarding to symptom severity. [2010.02]
Safety and tolerability of levocetirizine dihydrochloride in infants and children
with allergic rhinitis or chronic urticaria. [2010]
Efficacy and safety of levocetirizine in improving symptoms and health-related
quality of life in US adults with seasonal allergic rhinitis: a randomized,
placebo-controlled study. [2010]
Study of levocetirizine in seasonal allergic rhinitis. [2010]
The effectiveness of levocetirizine and desloratadine in up to 4 times
conventional doses in difficult-to-treat urticaria. [2010]
The effects of bilastine compared with cetirizine, fexofenadine, and placebo on
allergen-induced nasal and ocular symptoms in patients exposed to aeroallergen in
the Vienna Challenge Chamber. [2010]
Comparison of the efficacy of levocetirizine 5 mg and desloratadine 5 mg in chronic idiopathic urticaria patients. [2009.04]
Effect of levocetirizine on nasal provocation testing with adenosine monophosphate compared with allergen challenge in allergic rhinitis. [2009.03]
A combination of cetirizine and pseudoephedrine has therapeutic benefits when compared to single drug treatment in allergic rhinitis. [2009.02]
Pharmacokinetics and bioequivalence study of two cetirizine hydrochloride formulations in healthy Chinese male volunteers. [2009]
Hydroxyzine and cetirizine pharmacokinetics and pharmacodynamics after oral and intravenous administration of hydroxyzine to healthy dogs. [2008.12]
Levocetirizine in persistent allergic rhinitis: continuous or on-demand use? A pilot study. [2008.10]
Efficacy comparison of levocetirizine vs montelukast in ragweed sensitized patients. [2008.09]
A 12-week placebo-controlled study of rupatadine 10 mg once daily compared with cetirizine 10 mg once daily, in the treatment of persistent allergic rhinitis. [2008.07]
Efficacy of levocetirizine compared with montelukast in subjects with ragweed-induced seasonal allergic rhinitis in the Environmental Exposure Unit. [2008.05]
Determination of levocetirizine in human plasma by liquid chromatography-electrospray tandem mass spectrometry: application to a bioequivalence study. [2008.02.01]
Inhibition of allergen-induced wheal and flare reactions by levocetirizine and desloratadine. [2008.02]
Quality of life in patients with persistent allergic rhinitis treated with montelukast alone or in combination with levocetirizine or desloratadine. [2008]
Levocetirizine does not prolong the QT/QTc interval in healthy subjects: results from a thorough QT study. [2007.11]
Safety of levocetirizine treatment in young atopic children: An 18-month study. [2007.09]
Clinical efficacy and pharmacokinetic profiles of intranasal and oral cetirizine in a repeated allergen challenge model of allergic rhinitis. [2007.04]
Cetirizine, doxepine, and hydroxyzine in the treatment of pruritus due to sulfur mustard: a randomized clinical trial. [2007]
Montelukast with desloratadine or levocetirizine for the treatment of persistent allergic rhinitis. [2006.11]
[The effect of 5-days of cetirizine, desloratadine, fexofenadine 120 and 180 mg, levocetirizine, loratadine treatment on the histamine-induced skin reaction and skin blood flow--a randomized, double-blind, placebo controlled trial] [2006.11]
[Inhibition of histamine-induced wheel after a recommended single dose administration of 10 mg cetirizine, 5 mg desloratadine, 120 i 180 mg fexofenadine, 5 mg levocetirizine and 10 mg loratadine--a randomized, double-blind, placebo controlled trial] [2006.11]
Levocetirizine improves health-related quality of life and health status in persistent allergic rhinitis. [2006.10]
Comparison of cetirizine-pseudoephedrine and placebo in patients with seasonal allergic rhinitis and concomitant mild-to-moderate asthma: randomized, double-blind study. [2006.09]
Impact of azelastine nasal spray on symptoms and quality of life compared with cetirizine oral tablets in patients with seasonal allergic rhinitis. [2006.09]
Levocetirizine in persistent allergic rhinitis and asthma: effects on symptoms, quality of life and inflammatory parameters. [2006.09]
Facial thermography is a sensitive tool to determine antihistaminic activity: comparison of levocetirizine and fexofenadine. [2006.08]
A randomized controlled trial of cetirizine plus pseudoephedrine versus loratadine plus pseudoephedrine for perennial allergic rhinitis. [2006.06]
A comparison of levocetirizine and desloratadine in the histamine-induced wheal and flare response in human skin in vivo. [2006.06]
Effects of levocetirizine as add-on therapy to fluticasone in seasonal allergic rhinitis. [2006.05]
Levocetirizine is an effective treatment in patients suffering from chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled, parallel, multicenter study. [2006.04]
Severe arrhythmia as a result of the interaction of cetirizine and pilsicainide in a patient with renal insufficiency: first case presentation showing competition for excretion via renal multidrug resistance protein 1 and organic cation transporter 2. [2006.04]
Levocetirizine in the treatment of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study. [2006.03]
Randomized placebo-controlled trial comparing montelukast and cetirizine for treating perennial allergic rhinitis in children aged 2-6 yr. [2006.02]
Repeated-dose effects of mequitazine, cetirizine and dexchlorpheniramine on driving and psychomotor performance. [2006.01]
Evaluation of the cognitive, psychomotor and pharmacokinetic profiles of rupatadine, hydroxyzine and cetirizine, in combination with alcohol, in healthy volunteers. [2006.01]
Theophylline as 'add-on' therapy to cetirizine in patients with chronic idiopathic urticaria. A randomized, double-blind, placebo-controlled pilot study. [2006]
Comparison of the risk of drowsiness and sedation between levocetirizine and desloratadine: a prescription-event monitoring study in England. [2006]
Desloratadine and levocetirizine improve nasal symptoms, airflow, and allergic inflammation in patients with perennial allergic rhinitis: a pilot study. [2005.12]
Effect of cetirizine dihydrochloride on the airway response to hypertonic saline aerosol in patients with chronic obstructive pulmonary disease (COPD). [2005.10]
Efficacy and safety of levocetirizine on symptoms and health-related quality of life of children with perennial allergic rhinitis: a double-blind, placebo-controlled randomized clinical trial. [2005.08]
Comparative efficacy of cetirizine and fexofenadine for seasonal allergic rhinitis, 5-12 hours postdose, in the environmental exposure unit. [2005.07]
Levocetirizine has a longer duration of action on improving total nasal symptoms score than fexofenadine after single administration. [2005.07]
Costs associated with persistent allergic rhinitis are reduced by levocetirizine. [2005.06]
Effectiveness of azelastine nasal spray compared with oral cetirizine in patients with seasonal allergic rhinitis. [2005.05]
Levocetirizine in children: evidenced efficacy and safety in a 6-week randomized seasonal allergic rhinitis trial. [2005.05]
Population pharmacokinetics of levocetirizine in very young children: the pediatricians' perspective. [2005.03]
Double-blind, crossover comparison of olopatadine and cetirizine versus placebo: suppressive effects on skin response to histamine iontophoresis. [2005.01]
Levocetirizine improves nasal symptoms and airflow in patients with persistent allergic rhinitis: a pilot study. [2005.01]
Retrospective population pharmacokinetics of levocetirizine in atopic children receiving cetirizine: the ETAC study. [2005.01]
Efficacy and safety of an oral formulation of cetirizine and prolonged-release pseudoephedrine versus budesonide nasal spray in the management of nasal congestion in allergic rhinitis. [2005]
Rupatadine 10 mg and cetirizine 10 mg in seasonal allergic rhinitis: a randomised, double-blind parallel study. [2005]
Effects of cetirizine on substance P release in patients with perennial allergic rhinitis. [2004.12]
Similar rapid onset of action and magnitude of effect of fexofenadine and cetirizine as assessed by inhibition of histamine-induced wheal-and-flare reaction. [2004.12]
An evaluation of the ocular drying effects of 2 systemic antihistamines: loratadine and cetirizine hydrochloride. [2004.11]
Failure of cetirizine to prevent nevirapine-associated rash: a double-blind placebo-controlled trial for the GESIDA 26/01 Study. [2004.10.01]
Levocetirizine improves quality of life and reduces costs in long-term management of persistent allergic rhinitis. [2004.10]
Comparison of the effects in the nose and skin of a single dose of desloratadine and levocetirizine over 24 hours. [2004.10]
Effects of bepotastine, cetirizine, fexofenadine, and olopatadine on histamine-induced wheal-and flare-response, sedation, and psychomotor performance. [2004.09]
Single and short-term dosing effects of levocetirizine on adenosine monophosphate bronchoprovocation in atopic asthma. [2004.07]
Cetirizine reduces cytokines and inflammatory cells in children with perennial allergic rhinitis. [2004.06]
Comparative activity of cetirizine and desloratadine on histamine-induced wheal-and-flare responses during 24 hours. [2004.06]
A direct comparison of the efficacy of antihistamines in SAR and PAR: randomised, placebo-controlled studies with levocetirizine and loratadine using an environmental exposure unit - the Vienna Challenge Chamber (VCC). [2004.06]
Levocetirizine improves nasal obstruction and modulates cytokine pattern in patients with seasonal allergic rhinitis: a pilot study. [2004.06]
Assessment of cetirizine, an antihistamine, to prevent cutaneous reactions to nevirapine therapy: results of the viramune-zyrtec double-blind, placebo-controlled trial. [2004.04.15]
Levocetirizine better protects than desloratadine in a nasal provocation with allergen. [2004.04]
Comparative effects of desloratadine, fexofenadine, and levocetirizine on nasal adenosine monophosphate challenge in patients with perennial allergic rhinitis. [2004.04]
Montelukast plus cetirizine in the prophylactic treatment of seasonal allergic rhinitis: influence on clinical symptoms and nasal allergic inflammation. [2004.03]
Comparative clinical efficacy, onset and duration of action of levocetirizine and desloratadine for symptoms of seasonal allergic rhinitis in subjects evaluated in the Environmental Exposure Unit (EEU). [2004.02]
Randomized placebo-controlled trial comparing fluticasone aqueous nasal spray in mono-therapy, fluticasone plus cetirizine, fluticasone plus montelukast and cetirizine plus montelukast for seasonal allergic rhinitis. [2004.02]
A dose-ranging study of the effects of mequitazine on actual driving, memory and psychomotor performance as compared to dexchlorpheniramine, cetirizine and placebo. [2004.02]
Randomized double-blind comparison of cetirizine and fexofenadine after pollen challenge in the Environmental Exposure Unit: duration of effect in subjects with seasonal allergic rhinitis. [2004.01]
Comparative efficacy of cetirizine and fexofenadine in the treatment of chronic idiopathic urticaria. [2004.01]
The addition of zafirlukast to cetirizine improves the treatment of chronic urticaria in patients with positive autologous serum skin test results. [2004.01]
Clinical study of the therapeutic efficacy and safety of emedastine difumarate versus cetirizine in the treatment of seasonal allergic rhinitis. [2004]
Fexofenadine hydrochloride, 180 mg, exhibits equivalent efficacy to cetirizine, 10 mg, with less drowsiness in patients with moderate-to-severe seasonal allergic rhinitis. [2003.10]
Comparison of the effects of desloratadine and levocetirizine on histamine-induced wheal, flare and itch in human skin. [2003.10]
Twenty-four-hour activity and consistency of activity of levocetirizine and desloratadine in the skin. [2003.10]
Levocetirizine is effective for symptom relief including nasal congestion in adolescent and adult (PAR) sensitized to house dust mites. [2003.09]
Driving ability after acute and sub-chronic administration of levocetirizine and diphenhydramine: a randomized, double-blind, placebo-controlled trial. [2003.08]
Safety of cetirizine in infants 6 to 11 months of age: a randomized, double-blind, placebo-controlled study. [2003.06]
|
